Biogen Inc.; Envisagenics: Biogen and Envisagenics Announce Collaboration to Advance RNA Splicing Research
Biogen Inc.; Envisagenics: Biogen and Envisagenics Announce Collaboration to Advance RNA Splicing Research As part of the agreement, Biogen will leverage Envisagenics' AI platform with the goal of better understanding Central Nervous System diseases CAMBRIDGE, Mass. and NEW YORK, May 13, 2021today announced a new collaboration to advance ribonucleic acid (RNA) splicing research within central nervous system (CNS) diseases. As part of the collaboration, Biogen will leverage Envisagenics' proprietary artificial intelligence (AI)-driven RNA splicing platform, SpliceCore , to define and understan...